ES2157920T3 - Procedimiento para recuperar un complejo factor viii/factor von willebrand inactivado de virus y de elevada pureza mediante cromatografia de intercambio anionico. - Google Patents

Procedimiento para recuperar un complejo factor viii/factor von willebrand inactivado de virus y de elevada pureza mediante cromatografia de intercambio anionico.

Info

Publication number
ES2157920T3
ES2157920T3 ES93902233T ES93902233T ES2157920T3 ES 2157920 T3 ES2157920 T3 ES 2157920T3 ES 93902233 T ES93902233 T ES 93902233T ES 93902233 T ES93902233 T ES 93902233T ES 2157920 T3 ES2157920 T3 ES 2157920T3
Authority
ES
Spain
Prior art keywords
viruses
recovering
procedure
high purity
exchange chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902233T
Other languages
English (en)
Other versions
ES2157920T5 (es
Inventor
Monika Stadler
Horst Schwinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6451895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2157920(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma AG filed Critical Octapharma AG
Application granted granted Critical
Publication of ES2157920T3 publication Critical patent/ES2157920T3/es
Publication of ES2157920T5 publication Critical patent/ES2157920T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DESCRIBE UN PROCESO ECONOMICO PARA LA RECUPERACION DEL FACTOR VIII DEL PLASMA SANGUINEO O CRIOPRECIPITADO. EN DICHO PROCESO, LA CROMATOGRAFIA INTERCAMBIADORA DE ANION SE REALIZA UTILIZANDO UN MATERIAL DE SEPARACION BASADO EN PORTADORES QUE CONTIENEN GRUPOS HIDROXIL, ESTANDO CUBIERTAS LAS SUPERFICIES DE TALES PORTADORES CON POLIMEROS LIGADOS COVALENTEMENTE, CONTENIENDO DICHOS POLIMEROS UNIDADES DE REPETICION REPRESENTADOS POR LA FORMULA (I) DONDE R1, R'' Y R", Y Y N ESTAN DEFINIDOS EN LA LLAMADA 1.
ES93902233T 1992-02-01 1993-01-20 Procedimiento para recuperar un complejo factor viii/factor von willebrand inactivado de virus y de elevada pureza mediante cromatografia de intercambio anionico. Expired - Lifetime ES2157920T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4204694A DE4204694C3 (de) 1992-02-01 1992-02-01 Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
DE4204694 1992-02-01

Publications (2)

Publication Number Publication Date
ES2157920T3 true ES2157920T3 (es) 2001-09-01
ES2157920T5 ES2157920T5 (es) 2007-12-16

Family

ID=6451895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902233T Expired - Lifetime ES2157920T5 (es) 1992-02-01 1993-01-20 Procedimiento para recuperar un complejo factor viii/factor von willebrand inactivado de virus y de elevada pureza mediante cromatografia de intercambio anionico.

Country Status (16)

Country Link
US (1) US5714590A (es)
EP (1) EP0625161B9 (es)
JP (1) JP3556947B2 (es)
KR (1) KR100240310B1 (es)
AT (1) ATE203249T1 (es)
AU (1) AU670776B2 (es)
DE (2) DE4204694C3 (es)
DK (1) DK0625161T4 (es)
ES (1) ES2157920T5 (es)
FI (1) FI109908B (es)
GR (1) GR3036849T3 (es)
NO (1) NO315426B1 (es)
PT (1) PT625161E (es)
RU (1) RU2096414C1 (es)
TW (1) TW362099B (es)
WO (1) WO1993015105A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0602173B1 (en) * 1991-09-05 1999-05-26 Baxter International Inc. Topical fibrinogen complex
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
RU2253475C1 (ru) * 2004-02-02 2005-06-10 Общество с ограниченной ответственностью "Гемоцентр" Способ получения препарата фактора viii
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
RU2293570C2 (ru) * 2005-02-01 2007-02-20 Государственное учреждение Гематологический научный центр РАМН (ГУ ГНЦ РАМН) Способ обогащения фактором viii криопреципитата плазмы донорской крови
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
WO2011060242A2 (en) * 2009-11-13 2011-05-19 Talecris Biotherapeutics, Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE3811042A1 (de) * 1988-03-31 1989-10-19 Merck Patent Gmbh Ionenaustauscher
ES2053619T3 (es) * 1988-05-27 1994-08-01 Centre Regional De Transfusion Procedimiento para la fabricacion de un factor antihemofilico de gran pureza y libre de virus mediante cromatografia.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3878245D1 (de) * 1988-11-05 1993-03-18 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
NO315426B1 (no) 2003-09-01
AU670776B2 (en) 1996-08-01
NO942832D0 (no) 1994-07-29
ES2157920T5 (es) 2007-12-16
EP0625161B2 (en) 2007-05-16
US5714590A (en) 1998-02-03
ATE203249T1 (de) 2001-08-15
GR3036849T3 (en) 2002-01-31
EP0625161B1 (en) 2001-07-18
DK0625161T3 (da) 2001-09-24
EP0625161A1 (en) 1994-11-23
DE69330458T3 (de) 2008-01-17
DE4204694A1 (de) 1993-08-12
JP3556947B2 (ja) 2004-08-25
KR100240310B1 (ko) 2000-01-15
WO1993015105A1 (en) 1993-08-05
KR950700925A (ko) 1995-02-20
FI943545L (fi) 1994-07-28
TW362099B (en) 1999-06-21
FI109908B (fi) 2002-10-31
DE4204694C3 (de) 1995-10-12
AU3351793A (en) 1993-09-01
FI943545A0 (fi) 1994-07-28
JPH07503241A (ja) 1995-04-06
EP0625161B9 (en) 2007-09-19
DE4204694C2 (de) 1994-02-10
DK0625161T4 (da) 2007-09-03
RU2096414C1 (ru) 1997-11-20
DE69330458D1 (de) 2001-08-23
PT625161E (pt) 2001-10-31
DE69330458T2 (de) 2002-05-29
NO942832L (no) 1994-07-29

Similar Documents

Publication Publication Date Title
ES2157920T3 (es) Procedimiento para recuperar un complejo factor viii/factor von willebrand inactivado de virus y de elevada pureza mediante cromatografia de intercambio anionico.
ATE124679T1 (de) Zurückgewinnung von ethylenglykol und dimethylterephthalat aus polyethylenterephthalat.
DE69229438D1 (de) Verfahren zum Dekontaminieren von radioaktiven Materialien
HU905797D0 (en) Process for the preparation of the complex concentrate of blood-coagulating factor (viii) and von willebrand factor from complex plasma
BR8501638A (pt) Processo de recuperacao e reciclagem de gas efluente da regeneracao de material particulado,com oxigenio e dioxido de carbono
JPS5653704A (en) Ultrafiltration
EP0079721A3 (en) N-vinyl lactam-based biomedical devices and process for preparation thereof
BE893855A (fr) Procede de recuperation d'oxyde d'ethylene de solutions aqueuses
IT1034827B (it) Processo per la rimozione ed il recupero di monomeri non reagiti da polimeri resinosi
IT8026442A0 (it) Processo di separazione per miscele gassose.
ITMI922778A1 (it) Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii: c-fvw) da plasma umano totale.
HUP0301211A2 (hu) Vérzéscsillapító hatású vWF-tartalmú készítmény és eljárás annak előállítására
ATE153318T1 (de) Entfernung von quecksilber aus abfallströmen
BR8306468A (pt) Processo para a preparacao de um polimero e sua aplicacao
ATE82992T1 (de) Verfahren zur entgasung von verschmolzenem polymethylenoxid.
ES8103185A1 (es) Un metodo para concentrar un material que contiene uranio y calcio en solucion
IT1084454B (it) Processo per il recupero di cloro e di ossido di ferro da miscugli impuri di cloruri contenenti cloruro di ferro (ii), sottoprodotti della clorurazione di materie prime contenenti titanio.
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
DK0564036T3 (da) Fremgangsmåde til rensning af en hydrofluoralkan
IT8125739A0 (it) Processo per il recupero di poli (vinil cloruro).
DE3360328D1 (en) Process for the preparation of 2-acyl-1,3,4,6,7,11b-2h-hexahydro-4-pyrazino(2,1-a)isoquinolinones and intermediates
IT1128596B (it) Procedimento di sintesi di agenti reticolanti idrosolubili per la preparazione di polimeri anionici e prodotto ottenuto
BR8907283A (pt) Membranas semi-permeaveis com regiao discriminatoria interna
GB1402751A (en) Ampholytic materials
FI834752A0 (fi) Kontinuerligt foerfarande foer framstaellning av homopolymerer eller kopolymerer av etylen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625161

Country of ref document: ES